SCHEMBL30057736

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL30744273	0.97	PRCP (0.47)	PRCPACEACE2CASP3MDM4
	SCHEMBL29613906	0.90	ACE (0.58)	ACEACE2LTA4H
	SCHEMBL29696658	0.90	ACE (0.58)	ACEACE2LTA4H
	SCHEMBL24579222	0.90	ACE (0.58)	ACEACE2LTA4H
	SCHEMBL29697676	0.90	ACE (0.58)	ACEACE2LTA4H
	SCHEMBL29583278	0.89	ACE (0.51)	PRCPACEACE2KMT2ALMNA
	SCHEMBL24580400	0.89	PRCP (0.52)	PRCPACEACE2MDM4TP53
	SCHEMBL30272489	0.89	PRCP (0.46)	PRCPACEACE2CASP3MDM4
	SCHEMBL31164831	0.87	ACE (0.54)	ACEACE2LTA4H
	SCHEMBL31164828	0.87	ACE (0.54)	ACEACE2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.